Glooko is a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum. We’re uniquely positioned to be the enterprise partner of choice for healthcare providers seeking to reduce glycemic risk, improve safety, and support overburdened clinical teams with coordinated expertise across both outpatient and inpatient care settings. Our connected care solutions portfolio includes the outpatient Glooko diabetes management platform, Glooko Mobile App for people with diabetes, inpatient EndoTool Glucose Management System, and the Glooko XT remote patient monitoring platform in France.
All legitimate Glooko job opportunities are posted on our official careers page. Glooko will never ask candidates to pay for resume services, candidate validation, equipment, training, background checks, or any other hiring-related fees as part of the interview or hiring process. If you receive suspicious outreach claiming to be from Glooko or a Glooko employee, please verify the opportunity through our official careers page before engaging further.
DermTech 2.0 provides genomic analysis of skin samples collected non-invasively using its proprietary Smart Sticker platform technology. DermTech 2.0 develops and markets products to facilitate the assessment of melanoma, including the DermTech Melanoma Test, and offers DermTech Stratum, a precision biomarker service offering for biopharmaceutical and research partners.